Clinical Trials Browser

Phase 2 × Glioma × Cetuximab × Clear all

NCT00463073 2008-12-11

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Phase 2 Completed

Glioma